Search Results

• • 1 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• TAK1-inhibitors did not reduce disease burden in a Vκ*MYC model of multiple myeloma.

  Authors:Erling Håland, Ingrid Nyhus Moen, Esten N. Vandsemb, and Kristian K. StarheimFrom:BMC Research Notes (Vol. 15, Issue 1) Peer-Reviewed

  Nov. 26, 20222,019 words Report 1350LObjective Multiple myeloma is a haematological malignancy characterized by proliferation of monoclonal plasma cells in the bone marrow. Development of resistance and minimal residual disease remain challenging in the...